Branched-chain amino acids.
The branched-chain amino acids (BCAA), isoleucine, leucine and valine, are unique in that they are principally metabolized extrahepatically in the skeletal muscle. This observation led to the investigation of these nutrients in a number of clinical scenarios. By far the most intensively studied applications for BCAA have been in patients with liver failure and/or patients in catabolic disease states. However, the resulting studies have not demonstrated a clear clinical benefit for BCAA nutritional supplements. In patients with liver failure, the BCAA did improve nitrogen retention and protein synthesis, but their effect on patient outcome was less clear. Similarly, in critically ill septic patients, BCAA did not improve either survival or morbidity. The BCAA are important nutrients, and it seems that any specific benefits associated with their use will be based upon a greater understanding of the underlying cellular biology. Potential areas of further research may include the combination of BCAA supplements with other anabolic factors (e.g. growth hormone) in managing patients with catabolic disease states.
University Department of Surgery at Fremantle Hospital, Perth, Western Australia, Australia.
C
C
Platell
S E
SE
Kong
R
R
McCauley
J C
JC
Hall
D000597:Amino Acids, Branched-Chain / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D002331:Carnitine / Q000378:metabolism; D015444:Exercise / Q000502:physiology; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D012119:Respiration
D000597:Amino Acids, Branched-Chain; D018698:Glutamic Acid; D002331:Carnitine